PA

Parveen Abdul Samad Lakkundi

Active Director Director DIN 11067792
DIN 11067792 First appointment Apr 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Parveen Abdul Samad Lakkundi

Data last updated:

Parveen Abdul Samad Lakkundi is a Director at Medcip Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11067792
Primary Designation Director
Industry Pharma
First Appointment 21 Apr 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Apr 20252025Active

Board colleagues of Parveen Abdul Samad Lakkundi

Directorship timeline

Open interactive timeline →
Medcip Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Parveen Abdul Samad Lakkundi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Parveen Abdul Samad Lakkundi

Parveen Abdul Samad Lakkundi currently holds 1 directorship: Medcip Pharmaceuticals Private Limited (Director, since 21 Apr 2025).

Parveen Abdul Samad Lakkundi was first appointed on 21 Apr 2025 as Director at Medcip Pharmaceuticals Private Limited.

The current boards of Parveen Abdul Samad Lakkundi's companies include Shameena Roohi (Medcip Pharmaceuticals Private Limited), Yunus Noorul Ain Ansari (Medcip Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available